Cardiovascular autonomic dysfunction in multiple sclerosis: Correlation with orthostatic intolerance

Journal of Neurology

Volumn 246, Issue 7, 1999, Pages 578-586

  Flachenecker, Peter ^a   Wolf, Annalaska ^a   Krauser, Miriam ^a   Hartung, Hans Peter ^a,b   Reiners, Karlheinz ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

Autonomic dysfunction; Multiple sclerosis; Orthostatic intolerance; Power spectrum analysis; Sympathetic nervous system

Indexed keywords

ADRENERGIC SYSTEM; ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; BLOOD PRESSURE; BODY POSTURE; CARDIOVASCULAR REFLEX; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FUNCTION TEST; HAND GRIP; HEART RATE; HEART RATE VARIABILITY; HUMAN; HYPERPNEA; MALE; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUESTIONNAIRE; SPECTROSCOPY; STANDING; SYMPATHETIC FUNCTION; VALSALVA MANEUVER; VASOCONSTRICTION; VERTIGO;

ADULT; AUTONOMIC NERVOUS SYSTEM DISEASES; BLOOD PRESSURE; DISEASE PROGRESSION; DIZZINESS; FEMALE; HEART RATE; HUMANS; HYPOTENSION, ORTHOSTATIC; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; REFLEX;

EID: 0032810146     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050407     Document Type: Article

References (41)

1. 1. Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger AC, Cohen RJ (1981) Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 213:220-222
2. 2. Anema JR, Heijenbrok MW, Faes TJ, Heimans JJ, Lanting P, Polman CH (1991) Cardiovascular autonomic function in multiple sclerosis. J Neurol Sci 104:129-134
3. 3. Benarroch EE, Sandroni P, Low PA (1993) The Valsalva maneuver. In: Low PA (ed) Clinical autonomic disorders. Little-Brown, Boston, pp 209-216
4. 4. Chelmicka Schorr E, Arnason BG (1994) Nervous system-immune system interactions and their role in multiple sclerosis. Ann Neurol 36 [Suppl]: S29-S32
5. 5. Chelmicka-Schorr E, Checinski M, Arnason BG (1988) Chemical sympathectomy augments the severity of experimental allergic encephalomyelitis. J Neuroimmunol 17:347-350
6. 6. European Study Group on Interferon Beta-1b in Secondary Progressive MS (1998) Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis. Lancet 352:1491-1497
7. 7.Ewing DJ (1992) Analysis of heart rate variability and other noninvasive tests with special reference to diabetes mellitus. In: Bannister R, Mathias CJ (eds) Autonomic failure. A textbook of clinical disorders of the autonomic nervous system. Oxford University Press, New York, pp 312-333
8. 8. Ferini-Strambi L, Rovaris M, Oldani A, Martinelli V, Filippi M, Smirne S, Zucconi M, Comi G (1995) Cardiac autonomic function during sleep and wakefulness in multiple sclerosis. J Neurol 242:639-643
9. 9.Flachenecker P, Hartung HP, Reiners K (1997) Power spectrum analysis of heart rate variability in Guillain-Barré syndrome. A longitudinal study. Brain 120:1885-1894
10. 10.Flachenecker P, Wermuth P, Hartung HP, Reiners K (1997) Quantitative assessment of cardiovascular autonomic function in Guillain-Barré syndrome. Ann Neurol 42:171-179
11. 11. Frontoni M, Fiorini M, Strano S, Cerutti S, Giubilei F, Urani C, Bastianello S, Pozzilli C (1996) Power spectrum analysis contribution to the detection of cardiovascular dysautonomia in multiple sclerosis. Acta Neurol Scand 93:241-245
12. 12. Gallai V, Sarchielli P, Firenze C, Trequattrini A, Paciaroni M, Usai F, Franceschini M, Palumbo R (1994) Neuropeptide Y plasma levels and serum dopamine-beta-hydroxylase activity in MS patients with and without abnormal cardiovascular reflexes. Acta Neurol Belg 94:44-52
13. +, CD28-suppressor cell. Ann Neurol 30: 42-47
14. 14.Kuroda Y, Mori T, Hori T (1994) Restraint stress suppresses experimental allergic encephalomyelitis in Lewis rats. Brain Res Bull 34:15-17
15. 15.Kurtzke JF (1983) Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444-1452
16. 16. Linden D, Diehl RR, Berlit P (1995) Subclinical autonomic disturbances in multiple sclerosis. J Neurol 242:374-378
17. 17. Linden D, Diehl RR, Kretzschmar A, Berlit P (1997) Autonomic evaluation by means of standard tests and power spectral analysis in multiple sclerosis. Muscle Nerve 20:809-814
18. 18. Low PA (1993) Laboratory evaluation of autonomic failure. In: Low PA (ed) Clinical autonomic disorders. Little-Brown, Boston, pp 169-196
19. 19.Malik M, Camm AJ (1993) Components of heart rate variability - what they really mean and what we really measure. Am J Cardiol 72:821-822
20. 20. Matthews WB (1991) Clinical aspects - symptoms and signs. In: Matthews WB (ed) McAlpines's multiple sclerosis. Churchill Livingstone, New York, pp 43-78
21. 21.McLeod JG, Tuck RR (1987) Disorders of the autonomic nervous system: Part 2. Investigation and treatment. Ann Neurol 21:519-529
22. 22.Mutani R, Clemente S, Lamberti A, Monaco F (1982) Assessment of autonomic disturbances in multiple sclerosis by measurement of heart rate responses to deep breathing and to standing. Ital J Neurol Sci 2:111-114
23. 23. Nasseri K, TenVoorde BJ, Ader HJ, Uitdehaag BM, Polman CH (1998) Longitudinal follow-up of cardiovascular reflex tests in multiple sclerosis. J Neurol Sci 155:50-54
24. 24.Nordenbo AM, Boesen F, Andersen EB (1989) Cardiovascular autonomic function in multiple sclerosis. J Auton Nerv Syst 26:77-84
25. 25.Paty DW, Ebers GC (1998) Multiple sclerosis. Davis, Philadelphia
26. 26.Pentland B, Ewing DJ (1987) Cardiovascular reflexes in multiple sclerosis. Eur Neurol 26:46-50
27. 27. Pepin EB, Hicks RW, Spencer MK, Tran ZV, Jackson CGR (1996) Pressor response to isometric exercise in patients with multiple sclerosis. Med Sci Sports Exerc 28:656-660
28. 28. Pomeranz B, Macaulay RJ, Caudill MA, Kutz I, Adam D, Gordon D, Kilborn KM, Barger AC, Shannon DC, Cohen RJ, et al (1985) Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 248:H151-153
29. 29. PRISMS Study group (1998) Randomised double-blind placebo-controlled study of Interferon beta-1a in relapsing/remitting multiple sclerosis. Lancet 352:1498-1504
30. 30. Sakakibara R, Mori M, Fukutake T, Kita K, Hattori T (1997) Orthostatic hypotension in a case with multiple sclerosis. Clin Auton Res 7:163-165
31. 31. Sandroni P, Benarroch EE, Low PA (1991) Pharmacological dissection of components of the Valsalva maneuver in adrenergic failure. J Appl Physiol 71:1563-1567
32. 32. Senaratne MP, Carroll D, Warren KG, Kappagoda T (1984) Evidence for cardiovascular autonomic nerve dysfunction in multiple sclerosis. J Neurol Neurosurg Psychiatry 47:947-952
33. 33. Sharrack B, Hughes RAC (1996) Clinical scales for multiple sclerosis. J Neurol Sci 135:1-9
34. 34. Sterman AB, Coyle PK, Panasci DJ, Grimson R (1985) Disseminated abnormalities of cardiovascular autonomic function in multiple sclerosis. Neurology 35:1665-1668
35. 35. Therapeutics and Technology Assessment Subcommittee (1996) Clinical autonomic testing report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 46:873-880
36. 36.Thomaides TN, Zoukos Y, Chaudhuri KR, Mathias CJ (1993) Physiological assessment of aspects of autonomic function in patients with secondary progressive multiple sclerosis. J Neurol 240:139-143
37. 37.Thomaides TN, Zoukos Y, Chaudhuri KR, Watson L, Mathias CJ (1995) Central defects of autonomic function in secondary progressive multiple sclerosis: observations based on cardiovascular and growth hormone responses to clonidine. Eur J Neurol 2:163-169
38. 38. Vita G, Fazio MC, Milone S, Blandino A, Salvi L, Messina C (1993) Cardiovascular autonomic dysfunction in multiple sclerosis is likely related to brainstem lesions. J Neurol Sci 120: 82-86
39. 39. Wiegmann K, Muthyala S, Kim DH, Arnason BG, Chelmicka Schorr E (1995) Beta-adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats. J Neuroimmunol 56:201-206
40. 40. Wieling W (1992) Non-invasive continuous recording of heart rate and blood pressure in the evaluation of neurocardiovascular control. In: Bannister R, Mathias CJ (eds) Autonomic failure. A textbook of clinical disorders of the autonomic nervous system. Oxford University Press, New York, pp 291-311
41. 41. Zoukos Y, Kidd D, Woodroofe MN, Kendall BE, Thompson AJ, Cuzner ME (1994) Increased expression of high affinity IL-2 receptors and betaadrenoceptors on peripheral blood mononuclear cells is associated with clinical and MRI activity in multiple sclerosis. Brain 117:307-315